Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Koessler, Thibaud https://orcid.org/0000-0001-9196-9076
Alsina, Maria
Arnold, Dirk
Ben-Aharon, Irit
Lutz, Manfred P
Abstract
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial results have been reported, some leading to a change of practice. Furthermore, during ASCO-GI 2021, results from early phase trials have been presented, some with potential important implications for future treatments. We provide here an overview of these important results and their integration into routine clinical practice.
Description
Keywords
Clinical Trials as Topic, Congresses as Topic, Gastrointestinal Neoplasms, Humans, Immunotherapy, Molecular Targeted Therapy, Survival Analysis, Treatment Outcome
Journal Title
Br J Cancer
Conference Name
Journal ISSN
0007-0920
1532-1827
1532-1827
Volume Title
125
Publisher
Springer Science and Business Media LLC